Skip to main content

Mark Stevens

SEC CIK
0000933482
Latest filing
Oct 27, 2023

ABBV holding history

AbbVie Inc. in every 13F filed by Mark Stevens, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q3 2023 holdings

Shares (Q3 2023)
36,127
Value
$5.39M
% of portfolio
0.7%
Quarters held
11
Since Q1 2021
Holdings of ABBV by Mark Stevens, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 202336,127$5.39M0.7%+775+2.2%AddedHolders
Q2 202335,352$4.76M0.6%−809−2.2%ReducedHolders
Q1 202336,161$5.76M0.7%−2,873−7.4%ReducedHolders
Q4 202239,034$6.31M0.8%−7,306−15.8%ReducedHolders
Q3 202246,340$6.22M0.9%−4,168−8.3%ReducedHolders
Q2 202250,508$7.74M1.0%−1,831−3.5%ReducedHolders
Q1 202252,339$8.48M0.9%−4,297−7.6%ReducedHolders
Q4 202156,636$7.67M0.8%−1,780−3.0%ReducedHolders
Q3 202158,416$6.30M0.7%−1,451−2.4%ReducedHolders
Q2 202159,867$6.74M0.7%−4,336−6.8%ReducedHolders
Q1 202164,203$6.95M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.